Panlong Pharmaceutical: Ketoprofen Gel Patch received approval for clinical trials from the National Medical Products Administration.

Panlong Pharmaceutical Announcement: Recently, the company has received the Approval Notice for Drug Clinical Trial issued by the National Medical Products Administration, allowing the clinical trial of Ketoprofen Gel Plaster. Ketoprofen Gel Plaster, specifications: each plaster contains 10g of gel with 30mg of Ketoprofen. It is indicated for pain relief and anti-inflammatory effects in the following diseases and symptoms: osteoarthritis, shoulder periarthritis, tendinitis, tenosynovitis, lateral epicondylitis, muscle pain, swelling and pain due to trauma. The administration method is topical application, one plaster each time, twice a day. It is classified as a chemical drug of Category 3 in registration.